The development and implementation of the SWEET Peer Review Programme for pediatric diabetes centres

Related Experiment Video

Updated: Mar 5, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Stephen Parsons1, Sheridan Waldron2, Fiona Campbell3

  • 1SWEET Peer Review Programme, Independent Consultant, Kent, UK.

Pediatric Diabetes
|March 24, 2017
PubMed

Insights

This study details a peer review program for Pediatric Diabetes Centres within the SWEET Group, outlining its development, implementation, and management. Key findings and feedback aim to enhance future pediatric diabetes care quality.

Area of Science:

  • Pediatric Endocrinology
  • Healthcare Quality Improvement
  • Diabetes Management

Background:

  • The SWEET (Strengthening European Expertise in Pediatric Diabetes) network comprises numerous Pediatric Diabetes Centres.
  • Standardization and quality assessment are crucial for optimal pediatric diabetes care across centers.

Purpose of the Study:

  • To describe the establishment and management of a peer review program for SWEET Group Pediatric Diabetes Centres.
  • To outline the principles, intended outcomes, delivery methods, and findings of the peer review process.

Main Methods:

  • Development and implementation of a structured peer review program.
  • Review of 16 Pediatric Diabetes Centres to date.
  • Collection and analysis of feedback from reviewed centers and reviewers.

Main Results:

  • Summarizes key findings from the initial 16 center reviews.
  • Highlights participant feedback on the peer review process.
  • Identifies areas for program enhancement.

Conclusions:

  • The peer review program provides a framework for quality assessment in pediatric diabetes care.
  • Feedback indicates the program's value and suggests avenues for future development.
  • Continuous quality improvement is essential for specialized pediatric diabetes services.

Keywords:
Benefits to clinical outcomesClinical leadershipPeer reviewQuality assurance

More Related Videos

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells06:33

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Published on: February 2, 2024

2.8K
Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms08:16

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

2.2K

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
303
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
447
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
342
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
398